medmix AG (SIX: MEDX.SW) Stock Competitors & Peer Comparison
See MEDX.SW's competitors and their performance on the SIX and across the wider stock market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MEDX.SW and its SIX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MEDX.SW | CHF 9.01 | +0.22% | 366.5M | 12.51 | CHF 0.72 | +1.11% |
| SCHN.SW | CHF 247.50 | -1.39% | 27.2B | 34.96 | CHF 7.08 | +2.70% |
| SCHP.SW | CHF 252.20 | -1.18% | 26.9B | 26.60 | CHF 9.48 | +2.70% |
| VACN.SW | CHF 612.20 | +2.89% | 18.3B | 86.35 | CHF 7.09 | +1.14% |
| BEAN.SW | CHF 792.50 | +1.73% | 9.7B | 47.48 | CHF 16.69 | +1.26% |
| RAA.SW | CHF 615.00 | +0.00% | 7.7B | 48.08 | CHF 12.79 | +2.20% |
| ACLN.SW | CHF 73.35 | +1.52% | 6.9B | 33.46 | CHF 2.21 | +2.04% |
| KGX.SW | CHF 37.93 | +0.00% | 5B | 14.50 | CHF 2.62 | +1.53% |
| SUN.SW | CHF 145.50 | -1.56% | 4.9B | 19.04 | CHF 7.64 | +3.26% |
| GF.SW | CHF 55.30 | +1.00% | 4.5B | -32.98 | -CHF 1.68 | +2.44% |
Stock Comparison
Schindler Holding AG (SIX: SCHN.SW)
MEDX.SW vs SCHN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, SCHN.SW has a market cap of 27.2B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while SCHN.SW trades at CHF 247.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas SCHN.SW's P/E ratio is 34.96. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to SCHN.SW's ROE of +0.27%. Regarding short-term risk, MEDX.SW is more volatile compared to SCHN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check SCHN.SW's competition here
Schindler Holding AG (SIX: SCHP.SW)
MEDX.SW vs SCHP.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, SCHP.SW has a market cap of 26.9B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while SCHP.SW trades at CHF 252.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas SCHP.SW's P/E ratio is 26.60. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to SCHP.SW's ROE of +0.27%. Regarding short-term risk, MEDX.SW is more volatile compared to SCHP.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check SCHP.SW's competition here
VAT Group AG (SIX: VACN.SW)
MEDX.SW vs VACN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, VACN.SW has a market cap of 18.3B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while VACN.SW trades at CHF 612.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas VACN.SW's P/E ratio is 86.35. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to VACN.SW's ROE of +0.28%. Regarding short-term risk, MEDX.SW is more volatile compared to VACN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check VACN.SW's competition here
BELIMO Holding AG (SIX: BEAN.SW)
MEDX.SW vs BEAN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, BEAN.SW has a market cap of 9.7B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while BEAN.SW trades at CHF 792.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas BEAN.SW's P/E ratio is 47.48. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BEAN.SW's ROE of +0.33%. Regarding short-term risk, MEDX.SW is less volatile compared to BEAN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check BEAN.SW's competition here
Rational AG (SIX: RAA.SW)
MEDX.SW vs RAA.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, RAA.SW has a market cap of 7.7B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while RAA.SW trades at CHF 615.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas RAA.SW's P/E ratio is 48.08. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to RAA.SW's ROE of +0.28%. Regarding short-term risk, MEDX.SW is more volatile compared to RAA.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check RAA.SW's competition here
Accelleron Industries AG (SIX: ACLN.SW)
MEDX.SW vs ACLN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, ACLN.SW has a market cap of 6.9B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while ACLN.SW trades at CHF 73.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas ACLN.SW's P/E ratio is 33.46. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to ACLN.SW's ROE of +0.58%. Regarding short-term risk, MEDX.SW is less volatile compared to ACLN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check ACLN.SW's competition here
Kion Group AG (SIX: KGX.SW)
MEDX.SW vs KGX.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, KGX.SW has a market cap of 5B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while KGX.SW trades at CHF 37.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas KGX.SW's P/E ratio is 14.50. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KGX.SW's ROE of +0.06%. Regarding short-term risk, MEDX.SW is more volatile compared to KGX.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check KGX.SW's competition here
Sulzer Ltd (SIX: SUN.SW)
MEDX.SW vs SUN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, SUN.SW has a market cap of 4.9B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while SUN.SW trades at CHF 145.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas SUN.SW's P/E ratio is 19.04. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to SUN.SW's ROE of +0.23%. Regarding short-term risk, MEDX.SW is less volatile compared to SUN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check SUN.SW's competition here
Georg Fischer AG (SIX: GF.SW)
MEDX.SW vs GF.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, GF.SW has a market cap of 4.5B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while GF.SW trades at CHF 55.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas GF.SW's P/E ratio is -32.98. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to GF.SW's ROE of +8.38%. Regarding short-term risk, MEDX.SW is more volatile compared to GF.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check GF.SW's competition here
Jungheinrich AG (SIX: JUNGH.SW)
MEDX.SW vs JUNGH.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, JUNGH.SW has a market cap of 3.5B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while JUNGH.SW trades at CHF 30.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas JUNGH.SW's P/E ratio is 11.61. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to JUNGH.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to JUNGH.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check JUNGH.SW's competition here
KUKA AG (SIX: KU2.SW)
MEDX.SW vs KU2.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, KU2.SW has a market cap of 3.3B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while KU2.SW trades at CHF 53.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas KU2.SW's P/E ratio is 36.60. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KU2.SW's ROE of +0.05%. Regarding short-term risk, MEDX.SW is not fully comparable compared to KU2.SW. This indicates unavailable risk data in terms of short-term price fluctuations for MEDX.SW.Check KU2.SW's competition here
Bucher Industries AG (SIX: BUCN.SW)
MEDX.SW vs BUCN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, BUCN.SW has a market cap of 3.2B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while BUCN.SW trades at CHF 321.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas BUCN.SW's P/E ratio is 17.60. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BUCN.SW's ROE of +0.10%. Regarding short-term risk, MEDX.SW is more volatile compared to BUCN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check BUCN.SW's competition here
Kardex Holding AG (SIX: KARN.SW)
MEDX.SW vs KARN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, KARN.SW has a market cap of 1.8B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while KARN.SW trades at CHF 229.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas KARN.SW's P/E ratio is 45.52. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KARN.SW's ROE of +0.11%. Regarding short-term risk, MEDX.SW is less volatile compared to KARN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check KARN.SW's competition here
OC Oerlikon Corporation AG (SIX: OERL.SW)
MEDX.SW vs OERL.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, OERL.SW has a market cap of 1.8B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while OERL.SW trades at CHF 5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas OERL.SW's P/E ratio is 5.27. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to OERL.SW's ROE of +0.32%. Regarding short-term risk, MEDX.SW is less volatile compared to OERL.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check OERL.SW's competition here
Burckhardt Compression Holding AG (SIX: BCHN.SW)
MEDX.SW vs BCHN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, BCHN.SW has a market cap of 1.6B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while BCHN.SW trades at CHF 476.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas BCHN.SW's P/E ratio is 14.60. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BCHN.SW's ROE of +0.33%. Regarding short-term risk, MEDX.SW is more volatile compared to BCHN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check BCHN.SW's competition here
Interroll Holding AG (SIX: INRN.SW)
MEDX.SW vs INRN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, INRN.SW has a market cap of 1.2B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while INRN.SW trades at CHF 1,402.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas INRN.SW's P/E ratio is 21.42. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to INRN.SW's ROE of +0.11%. Regarding short-term risk, MEDX.SW is more volatile compared to INRN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check INRN.SW's competition here
Ballard Power Systems Inc. (SIX: BLD.SW)
MEDX.SW vs BLD.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, BLD.SW has a market cap of 1.2B. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while BLD.SW trades at CHF 3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas BLD.SW's P/E ratio is -6.66. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BLD.SW's ROE of -0.07%. Regarding short-term risk, MEDX.SW is more volatile compared to BLD.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check BLD.SW's competition here
Heidelberger Druckmaschinen AG (SIX: HDD.SW)
MEDX.SW vs HDD.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, HDD.SW has a market cap of 426.1M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while HDD.SW trades at CHF 1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas HDD.SW's P/E ratio is 30.01. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to HDD.SW's ROE of -0.01%. Regarding short-term risk, MEDX.SW is more volatile compared to HDD.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check HDD.SW's competition here
Phoenix Mecano AG (SIX: PMN.SW)
MEDX.SW vs PMN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, PMN.SW has a market cap of 416.7M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while PMN.SW trades at CHF 454.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas PMN.SW's P/E ratio is 14.85. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to PMN.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to PMN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check PMN.SW's competition here
Phoenix Mecano AG (SIX: PM.SW)
MEDX.SW vs PM.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, PM.SW has a market cap of 402.4M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while PM.SW trades at CHF 419.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas PM.SW's P/E ratio is 10.47. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to PM.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to PM.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check PM.SW's competition here
Komax Holding AG (SIX: KOMN.SW)
MEDX.SW vs KOMN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, KOMN.SW has a market cap of 371.6M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while KOMN.SW trades at CHF 72.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas KOMN.SW's P/E ratio is -39.62. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KOMN.SW's ROE of -0.03%. Regarding short-term risk, MEDX.SW is less volatile compared to KOMN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check KOMN.SW's competition here
Meier Tobler Group AG (SIX: MTG.SW)
MEDX.SW vs MTG.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, MTG.SW has a market cap of 353M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while MTG.SW trades at CHF 32.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas MTG.SW's P/E ratio is 17.68. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to MTG.SW's ROE of +0.10%. Regarding short-term risk, MEDX.SW is less volatile compared to MTG.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check MTG.SW's competition here
Bystronic AG (SIX: BYS.SW)
MEDX.SW vs BYS.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, BYS.SW has a market cap of 280.8M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while BYS.SW trades at CHF 136.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas BYS.SW's P/E ratio is -6.80. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BYS.SW's ROE of -0.07%. Regarding short-term risk, MEDX.SW is less volatile compared to BYS.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check BYS.SW's competition here
Mikron Holding AG (SIX: MIKN.SW)
MEDX.SW vs MIKN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, MIKN.SW has a market cap of 267M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while MIKN.SW trades at CHF 16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas MIKN.SW's P/E ratio is 9.52. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to MIKN.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is less volatile compared to MIKN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check MIKN.SW's competition here
Starrag Group Holding AG (SIX: STGN.SW)
MEDX.SW vs STGN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, STGN.SW has a market cap of 185.7M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while STGN.SW trades at CHF 34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas STGN.SW's P/E ratio is 12.83. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to STGN.SW's ROE of +0.05%. Regarding short-term risk, MEDX.SW is less volatile compared to STGN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check STGN.SW's competition here
Tornos Holding AG (SIX: TOHN.SW)
MEDX.SW vs TOHN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, TOHN.SW has a market cap of 101M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while TOHN.SW trades at CHF 5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas TOHN.SW's P/E ratio is 8.53. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to TOHN.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is less volatile compared to TOHN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check TOHN.SW's competition here
Klingelnberg AG (SIX: KLIN.SW)
MEDX.SW vs KLIN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, KLIN.SW has a market cap of 96.4M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while KLIN.SW trades at CHF 10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas KLIN.SW's P/E ratio is -36.38. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KLIN.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is less volatile compared to KLIN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check KLIN.SW's competition here
Rieter Holding AG (SIX: RIEN.SW)
MEDX.SW vs RIEN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, RIEN.SW has a market cap of 86.5M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while RIEN.SW trades at CHF 2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas RIEN.SW's P/E ratio is -0.91. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to RIEN.SW's ROE of -0.13%. Regarding short-term risk, MEDX.SW is less volatile compared to RIEN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check RIEN.SW's competition here
NORMA Group SE (SIX: NOEJ.SW)
MEDX.SW vs NOEJ.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, NOEJ.SW has a market cap of 70M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while NOEJ.SW trades at CHF 14.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas NOEJ.SW's P/E ratio is -8.83. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to NOEJ.SW's ROE of +0.34%. Regarding short-term risk, MEDX.SW is more volatile compared to NOEJ.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check NOEJ.SW's competition here
Schlatter Industries AG (SIX: STRN.SW)
MEDX.SW vs STRN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, STRN.SW has a market cap of 20.8M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while STRN.SW trades at CHF 18.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas STRN.SW's P/E ratio is 13.43. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to STRN.SW's ROE of +0.01%. Regarding short-term risk, MEDX.SW is less volatile compared to STRN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check STRN.SW's competition here
Perrot Duval Holding S.A. (SIX: PEDU.SW)
MEDX.SW vs PEDU.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, PEDU.SW has a market cap of 13.2M. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while PEDU.SW trades at CHF 110.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas PEDU.SW's P/E ratio is 12.33. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to PEDU.SW's ROE of -0.49%. Regarding short-term risk, MEDX.SW is more volatile compared to PEDU.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check PEDU.SW's competition here
Bobst Group S.A. (SIX: BOBNN.SW)
MEDX.SW vs BOBNN.SW Comparison September 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 366.5M. In comparison, BOBNN.SW has a market cap of 0. Regarding current trading prices, MEDX.SW is priced at CHF 9.01 on the SIX, while BOBNN.SW trades at CHF 57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 12.51, whereas BOBNN.SW's P/E ratio is N/A. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BOBNN.SW's ROE of +0.17%. Regarding short-term risk, MEDX.SW is less volatile compared to BOBNN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check BOBNN.SW's competition here